GAVISCON

Main information

  • Trade name:
  • GAVISCON oral suspension
  • Pharmaceutical form:
  • oral suspension
  • Prescription type:
  • No Prescription (OTC)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • GAVISCON oral suspension
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Alginic acid
  • Product summary:
  • Suitability for use in older adult patients Natrii hydrogenocarbonas Suitable for older persons. Natrii alginas Suitable for older persons. Calcii carbonas Suitable for older persons. Aluminii hydroxidum gel. Avoid use in older persons. Inappropriate as a laxative for older persons. Avoid use in even mild renal insufficiency. May cause adverse neurological effects. Take interactions in the absorption phase into account.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 8579
  • Authorization date:
  • 13-03-2008
  • Last update:
  • 26-07-2018